PainQx Awarded $1.5M Phase II SBIR Contract from the Defense Health Agency SBIR Program to Refine Objective Pain Assessment Technology
NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- PainQx, Inc. (www.painqx.com), a medical device company developing a next-generation approach to objectively assess chronic pain, is pleased to announce it has been awarded a Defense Health Agency (www.health.mil) Phase II SBIR contract. The DHA SBIR contract will enable PainQx to refine and expand the capabilities of its novel pain assessment technology, the ALGOS System. The PainQx ALGOS System is an AI-enabled software platform that uses electroence
Source: yahoo.com